Literature DB >> 20921405

NF-kappaB inhibits T-cell activation-induced, p73-dependent cell death by induction of MDM2.

Valere Busuttil1, Nathalie Droin, Laura McCormick, Francesca Bernassola, Eleonora Candi, Gerry Melino, Douglas R Green.   

Abstract

NF-κB is a key transcription factor involved in the regulation of T-cell activation and proliferation upon engagement of the T-cell receptor (TCR). T cells that lack the IκB kinase (IKKβ) are unable to activate NF-κB, and rapidly undergo apoptosis upon activation. NF-κB activation following T-cell receptor engagement induces the expression of Mdm2 through interaction with NF-κB sites in its P1 promoter, and enforced expression of Mdm2 protected T cells deficient for NF-κB activation from activation-induced cell death. In T cells with intact NF-κB signaling, ablation or pharmacologic inhibition of Mdm2 resulted in activation-induced apoptosis. Mdm2 coprecipitates with p73 in activated T cells, and apoptosis induced by inhibition of Mdm2 was p73-dependent. Further, Bim was identified as a p73 target gene required for cell death induced by Mdm2 inhibition, and a p73-responsive element in intron 1 of Bim was characterized. Our results demonstrate a pathway for survival of activated T cells through NF-κB-induced Mdm2, which blocks Bim-dependent apoptosis through binding and inhibition of p73.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20921405      PMCID: PMC2964227          DOI: 10.1073/pnas.1006163107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  49 in total

1.  PUMA, a novel proapoptotic gene, is induced by p53.

Authors:  K Nakano; K H Vousden
Journal:  Mol Cell       Date:  2001-03       Impact factor: 17.970

2.  RelA/NF-kappaB recruitment on the bax gene promoter antagonizes p73-dependent apoptosis in costimulated T cells.

Authors:  R Cianfrocca; M Muscolini; V Marzano; A Annibaldi; B Marinari; M Levrero; A Costanzo; L Tuosto
Journal:  Cell Death Differ       Date:  2007-11-23       Impact factor: 15.828

Review 3.  Measuring apoptosis at the single cell level.

Authors:  Lisa Bouchier-Hayes; Cristina Muñoz-Pinedo; Samuel Connell; Douglas R Green
Journal:  Methods       Date:  2008-03       Impact factor: 3.608

4.  An essential role for p73 in regulating mitotic cell death.

Authors:  W H Toh; S Y Nam; K Sabapathy
Journal:  Cell Death Differ       Date:  2009-12-11       Impact factor: 15.828

5.  IKKbeta is essential for protecting T cells from TNFalpha-induced apoptosis.

Authors:  U Senftleben; Z W Li; V Baud; M Karin
Journal:  Immunity       Date:  2001-03       Impact factor: 31.745

6.  NF-kappa B RelA (p65) is essential for TNF-alpha-induced fas expression but dispensable for both TCR-induced expression and activation-induced cell death.

Authors:  Y Zheng; F Ouaaz; P Bruzzo; V Singh; S Gerondakis; A A Beg
Journal:  J Immunol       Date:  2001-04-15       Impact factor: 5.422

7.  A common E2F-1 and p73 pathway mediates cell death induced by TCR activation.

Authors:  N A Lissy; P K Davis; M Irwin; W G Kaelin; S F Dowdy
Journal:  Nature       Date:  2000-10-05       Impact factor: 49.962

Review 8.  Regulation and function of NF-kappaB transcription factors in the immune system.

Authors:  Sivakumar Vallabhapurapu; Michael Karin
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

9.  Transcription factor Foxo3 controls the magnitude of T cell immune responses by modulating the function of dendritic cells.

Authors:  Anne S Dejean; Daniel R Beisner; Irene L Ch'en; Yann M Kerdiles; Anna Babour; Karen C Arden; Diego H Castrillon; Ronald A DePinho; Stephen M Hedrick
Journal:  Nat Immunol       Date:  2009-04-12       Impact factor: 25.606

Review 10.  The p53/p63/p73 family of transcription factors: overlapping and distinct functions.

Authors:  M Levrero; V De Laurenzi; A Costanzo; J Gong; J Y Wang; G Melino
Journal:  J Cell Sci       Date:  2000-05       Impact factor: 5.285

View more
  34 in total

Review 1.  Role of the nucleus in apoptosis: signaling and execution.

Authors:  Evgeniia A Prokhorova; Alexey V Zamaraev; Gelina S Kopeina; Boris Zhivotovsky; Inna N Lavrik
Journal:  Cell Mol Life Sci       Date:  2015-09-07       Impact factor: 9.261

2.  Micellar Delivery of miR-34a Modulator Rubone and Paclitaxel in Resistant Prostate Cancer.

Authors:  Di Wen; Yang Peng; Feng Lin; Rakesh K Singh; Ram I Mahato
Journal:  Cancer Res       Date:  2017-04-20       Impact factor: 12.701

3.  Mdm2 and MdmX as Regulators of Gene Expression.

Authors:  Lynn Biderman; James L Manley; Carol Prives
Journal:  Genes Cancer       Date:  2012-03

4.  The Involvement of Splicing Factor hnRNP A1 in UVB-induced Alternative Splicing of hdm2.

Authors:  Jianguo Feng; Li Li; Lingying Tong; Liling Tang; Shiyong Wu
Journal:  Photochem Photobiol       Date:  2016-02-11       Impact factor: 3.421

5.  The epigenetic regulator I-BET151 induces BIM-dependent apoptosis and cell cycle arrest of human melanoma cells.

Authors:  Stuart J Gallagher; Branka Mijatov; Dilini Gunatilake; Jessamy C Tiffen; Kavitha Gowrishankar; Lei Jin; Gulietta M Pupo; Carleen Cullinane; Rab K Prinjha; Nicholas Smithers; Grant A McArthur; Helen Rizos; Peter Hersey
Journal:  J Invest Dermatol       Date:  2014-06-06       Impact factor: 8.551

Review 6.  The p53 Saga: Early Steps in the Development of Tumor Immunotherapy.

Authors:  Albert B DeLeo; Ettore Appella
Journal:  J Immunol       Date:  2020-05-01       Impact factor: 5.422

Review 7.  Mdm2 links genotoxic stress and metabolism to p53.

Authors:  Zhongfeng Wang; Baojie Li
Journal:  Protein Cell       Date:  2011-01-08       Impact factor: 14.870

8.  Transcription factor NFAT1 activates the mdm2 oncogene independent of p53.

Authors:  Xu Zhang; Zhuo Zhang; Jianwen Cheng; Mao Li; Wei Wang; Wenrong Xu; Hui Wang; Ruiwen Zhang
Journal:  J Biol Chem       Date:  2012-07-11       Impact factor: 5.157

9.  The Many Faces of MDM2 Binding Partners.

Authors:  Maurisa F Riley; Guillermina Lozano
Journal:  Genes Cancer       Date:  2012-03

Review 10.  Targeting MDM2 for novel molecular therapy: Beyond oncology.

Authors:  Wei Wang; Jiang-Jiang Qin; Mehrdad Rajaei; Xin Li; Xiaoyi Yu; Courtney Hunt; Ruiwen Zhang
Journal:  Med Res Rev       Date:  2019-10-06       Impact factor: 12.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.